NTFS

American Century Championship Introduces its First-Ever NFT Charity Auction -- American Century Tees Up Fan Participation and Prizes with ACC Fantasy Golf and NFTs Benefitting Medical Research

Retrieved on: 
Tuesday, June 28, 2022

SOUTH LAKE TAHOE, Nev., June 28, 2022 /PRNewswire/ -- A new and innovative NFT charity auction will take place during this year's prestigious American Century Championship sponsored by American Century Investments. Since 1999, American Century has been the title sponsor of the American Century Championship, the premier celebrity golf tournament that has raised more than $6 million for dozens of worthy causes and nonprofits.

Key Points: 
  • SOUTH LAKE TAHOE, Nev., June 28, 2022 /PRNewswire/ -- A new and innovative NFT charity auction will take place during this year's prestigious American Century Championship sponsored by American Century Investments.
  • "We look forward to the American Century Championship, an amazing tournament with exciting celebrities in a beautiful setting each year.
  • "This year, we are excited not just to bring back the fan-favorite ACC Fantasy Golf, but to launch our first-ever NFT charity auction.
  • Anyone can participate in the American Century Championship NFT charity auction by making a bid or purchase at www.myACCnft.com .

LBank Exchange Will List Coution Token (CTL) on June 7, 2022

Retrieved on: 
Monday, June 6, 2022

Internet City, Dubai--(Newsfile Corp. - June 6, 2022) - LBank Exchange, a global digital asset trading platform, will list Coution Token (CTL) on June 7, 2022.

Key Points: 
  • Internet City, Dubai--(Newsfile Corp. - June 6, 2022) - LBank Exchange, a global digital asset trading platform, will list Coution Token (CTL) on June 7, 2022.
  • Its native token Coution Token (CTL) will be listed on LBank Exchange at 14:00 (UTC+8) on June 7, 2022, to further expand its global reach and help it achieve its vision.
  • Coution Live Project's native token Coution Token (CTL) allows users to pay for live streaming and give gifts to copyright holders.
  • The CTL token will be listed on LBank Exchange at 14:00 (UTC+8) on June 7, 2022, investors who are interested in the Coution Live Project investment can easily buy and sell CTL token on LBank Exchange by then.

Tenorshare 4DDiG Rolls Out The Brand New 9.0 Version With 30% Off

Retrieved on: 
Tuesday, May 24, 2022

NEW YORK, May 24, 2022 /PRNewswire/ -- Tenorshare 4DDiG is one of the world's most well-known data recovery software that has been developed to fulfill all recovery needs. With significant improvements in terms of user experience and comprehensive data recovery features, Tenorshare 4DDiG has upgraded to Windows 9.0 version. The new version of Tenorshare 4DDiG offers users the best data recovery solution with an upgraded interface and powerful functions that help them retrieve lost data successfully.

Key Points: 
  • NEW YORK, May 24, 2022 /PRNewswire/ -- Tenorshare 4DDiG is one of the world's most well-known data recovery software that has been developed to fulfill all recovery needs.
  • With significant improvements in terms of user experience and comprehensive data recovery features, Tenorshare 4DDiG has upgraded to Windows 9.0 version.
  • The new version of Tenorshare 4DDiG offers users the best data recovery solution with an upgraded interface and powerful functions that help them retrieve lost data successfully.
  • The latest upgrade of Tenorshare 4DDiG is for all kinds of file loss situations.

Energy8 Labs Introduces Latest Bridge Solutions for GameFi Sector

Retrieved on: 
Friday, May 13, 2022

NEW YORK, NY, May 13, 2022 (GLOBE NEWSWIRE) -- Recently, Energy8 Labs has introduced the latest bridge solutions for GameFi industry.

Key Points: 
  • NEW YORK, NY, May 13, 2022 (GLOBE NEWSWIRE) -- Recently, Energy8 Labs has introduced the latest bridge solutions for GameFi industry.
  • The main idea of Energy8 is to connect the world of blockchain technology and the gaming industry.
  • The GameFi sector is growing at a tremendous pace.
  • With more than 2.65 billion mobile game users worldwide, it definitely needs a new push that Energy8 Labs can provide.

Cybereason Uncovers Global Chinese Espionage Campaign Targeting Manufacturers in North America, Europe and Asia

Retrieved on: 
Wednesday, May 4, 2022

BOSTON, May 4, 2022 /PRNewswire-PRWeb/ -- Cybereason, the XDR company, today published new research on Operation CuckooBees, a 12 month investigation into Winnti Group's (APT 41) global cyber espionage campaign targeting manufacturers across North America, Europe and Asia in the Defense, Energy, Aerospace, Biotech and Pharma industries.

Key Points: 
  • Cybereason published two reports, the first examining the tactics and techniques of the overall campaign, and the second providing a detailed analysis of the malware and exploits used.
  • Multi-Year Cyber Espionage Intrusions: The Cybereason IR team investigated a sophisticated and elusive cyber espionage operation with the goal of stealing sensitive proprietary information from technology and manufacturing companies mainly in East Asia, Western Europe, and North America.
  • Cybereason is the XDR company, partnering with Defenders to end attacks at the endpoint, in the cloud and across the entire enterprise ecosystem.
  • Cybereason is a privately held international company headquartered in Boston with customers in more than 40 countries.

BrainStorm Announces Presentation of NurOwn® Exosome Preclinical Data at ISCT 2022 San Francisco Meeting

Retrieved on: 
Wednesday, May 4, 2022

NEW YORK, May 4, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced the presentation today of a poster titled, "MSC-NTF derived small extracellular vesicles display superior macrophage immunomodulation compared with vesicles derived from naïve MSCs," at the International Society of  Cell & Gene Therapy ISCT 2022 Meeting, being held from May 4-7, 2022 in San Francisco, CA. The poster will be presented by Dr. Kim Thacker, Senior Vice President, Medical Affairs and Clinical Innovation, BrainStorm Cell Therapeutics.

Key Points: 
  • The poster will be presented by Dr. Kim Thacker, Senior Vice President, Medical Affairs and Clinical Innovation, BrainStorm Cell Therapeutics.
  • Exo MSC-NTF treatment led to statistically significant 6.4 and 3.3-fold reductions in the secretion and transcription (gene expression) of the pro-inflammatory cytokine MCP-1.
  • "These compelling preclinical data provide important insights into Exo MSC-NTF's mechanism of action," said Ralph Kern, MD MHSc, President and Chief Medical Officer of BrainStorm.
  • BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.

BrainStorm to Announce First Quarter 2022 Financial Results and Provide a Corporate Update

Retrieved on: 
Monday, May 2, 2022

The NurOwn technology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders.

Key Points: 
  • The NurOwn technology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders.
  • MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo.
  • MSCs are converted into MSC-NTF cells by growing them under patented conditions that induce the cells to secrete high levels of neurotrophic factors (NTFs).
  • BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.

Calgary Fintech Offers Employees NFTs as Compensation Giving Them a Leg Up in the Battle for Top Talent

Retrieved on: 
Friday, April 1, 2022

The program was secretly piloted in Q1 of 2022 and has seen overwhelming success in attracting high caliber candidates.

Key Points: 
  • The program was secretly piloted in Q1 of 2022 and has seen overwhelming success in attracting high caliber candidates.
  • We are thrilled to integrate NFT options into our employees compensation packages.
  • Every two weeks, our employees get to choose from a gallery of NTFs that are priced based on fair market value.
  • Helcim serves thousands of businesses in Canada and the US across 800 different industries, processing billions in payments each year.

Brainstorm Cell Therapeutics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT

Retrieved on: 
Monday, March 28, 2022

The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.

Key Points: 
  • The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.
  • The NurOwn technology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders.
  • MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo.
  • Brainstorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.

BrainStorm Cell Therapeutics Abstract Selected as Late-Breaking Presentation at the 2022 MDA Clinical & Scientific Conference

Retrieved on: 
Monday, February 28, 2022

NEW YORK, Feb. 28, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.(NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the acceptance of a scientific abstract as a late-breaking oral presentation at the 2022 MDA (Muscular Dystrophy Association) Clinical & Scientific Conference, which is taking place virtually and in-person at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee from March 13 16, 2022.

Key Points: 
  • NEW YORK, Feb. 28, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.(NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the acceptance of a scientific abstract as a late-breaking oral presentation at the 2022 MDA (Muscular Dystrophy Association) Clinical & Scientific Conference, which is taking place virtually and in-person at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee from March 13 16, 2022.
  • A copy of the corresponding abstract is available on the 2022 MDA Clinical & Scientific Conference website .
  • MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo.
  • About BrainStorm Cell Therapeutics Inc.
    BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.